SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-371973
Filing Date
2015-11-09
Accepted
2015-11-09 16:21:22
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d23143d10q.htm 10-Q 264414
2 EX-31.1 d23143dex311.htm EX-31.1 5992
3 EX-31.2 d23143dex312.htm EX-31.2 6069
4 EX-32.1 d23143dex321.htm EX-32.1 4091
5 EX-32.2 d23143dex322.htm EX-32.2 4067
  Complete submission text file 0001193125-15-371973.txt   1894618

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ccxi-20150930.xml EX-101.INS 311767
7 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20150930.xsd EX-101.SCH 24817
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20150930_cal.xml EX-101.CAL 43336
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20150930_def.xml EX-101.DEF 47684
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20150930_lab.xml EX-101.LAB 196775
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20150930_pre.xml EX-101.PRE 139085
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 151215894
SIC: 2834 Pharmaceutical Preparations